FDA Inspection 1208600 — Weill Cornell Med College IRB
The FDA completed an inspection of Weill Cornell Med College IRB on June 7, 2023 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 7, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
IRB